Maintenance Therapy With Histamine Dihydrochloride and Interleukin-2 in Adult Acute Myeloid Leukemia (AML) Patients With Measurable Minimal Residual Disease (MRD)- a Non-interventional Study (NIS)

NCT01770158 · clinicaltrials.gov ↗
TERMINATED
Status
8
Enrollment
OTHER
Sponsor class

Stopped Recruitment goal cannot be achieved any more as only 8 patients have been recruited since start of the study in 2012.

Conditions

Sponsor

University of Ulm